Literature DB >> 25630666

Head and neck tuberculosis: 6-year retrospective study.

Carlos Miguel Chiesa Estomba1, Frank Alberto Betances Reinoso2, Teresa Rivera Schmitz2, Carla Cristina Ossa Echeverri2, María Jesús González Cortés2, Carmelo Santidrian Hidalgo2.   

Abstract

INTRODUCTION: Pulmonary involvement exists in 80% of cases of infection with Mycobacterium tuberculosis; however, in up to 20% of cases there may be extra-pulmonary involvement. In the ENT area, the most common site is cervical lymphadenitis, affecting approximately 95% of cases.
MATERIALS AND METHODS: This was a retrospective study of patients attending an ENT department in a tertiary hospital for head and neck symptoms that were diagnosed with tuberculosis (TB), between December 2007 and December 2013.
RESULTS: The study included 73 patients, 41 (56.2%) males and 32 (43.8%) females (M/F ratio=1.28), with a mean age of 39.4 years (± 26.5 years; Min 1, Max 88). There were 53 (72.6%) cases of cervical lymphadenopathy, 11 (15%) of laryngeal tuberculosis 3 (4.1%) of hypopharyngeal tuberculosis, and six cases in other locations. Of the total, 14 (19.2%) patients were HIV positive and 10 (13.7%) had a history of contact with relatives who had suffered pulmonary tuberculosis. PCR was performed in 51 (69.8%) cases to confirm being positive, of which 47 (92.1%) cases were.
CONCLUSION: The similarity of tuberculosis to diseases of poor prognosis and the difficulty of its diagnosis make considering tuberculosis necessary when exploring patients with ulcerative or granulomatous ENT lesions. Analysing our results, the incidence of TB according to its ENT area location is similar to that reported in the literature. It is important to make special mention of the use of PCR in our study and the benefits that its implementation means for diagnosis.
Copyright © 2014 Elsevier España, S.L.U. and Sociedad Española de Otorrinolaringología y Patología Cérvico-Facial. All rights reserved.

Entities:  

Keywords:  Cabeza; Cuello; Ear; Garganta; Head; Nariz; Neck; Nose; Oído; Throat; Tuberculosis

Mesh:

Year:  2015        PMID: 25630666     DOI: 10.1016/j.otorri.2014.11.003

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp        ISSN: 0001-6519


  5 in total

1.  Diagnostic dilemma in a patient with nasopharyngeal tuberculosis: A case report and literature review.

Authors:  Dorji Penjor; Birendra Pradhan
Journal:  SAGE Open Med Case Rep       Date:  2022-10-13

2.  Some Manifestations of Tuberculosis in Otorhinolaryngology - Case Series and a Short Review of Related Data from South-Eastern Europe.

Authors:  Adela-Ioana Mocanu; Cosmin Moldovan; Ioana Soare; Alin Laurentiu Tatu; Claudiu Ionut Vasile; Paraschiva A Postolache; Horia Mocanu; Elena Niculet; Daniela Diculencu; Alexandru Nechifor
Journal:  Infect Drug Resist       Date:  2022-05-31       Impact factor: 4.177

Review 3.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

Review 4.  Diagnostic challenges in cervical tuberculous lymphadenitis: A review.

Authors:  Hande Senem Deveci; Mustafa Kule; Zeynep Altin Kule; Tulay Erden Habesoglu
Journal:  North Clin Istanb       Date:  2016-09-28

Review 5.  Clinical study of tuberculosis in the head and neck region-11 years' experience and a review of the literature.

Authors:  Pai Pang; Weiyi Duan; Shuchun Liu; Shuang Bai; Yanan Ma; Ruiwu Li; Fayu Liu; Changfu Sun
Journal:  Emerg Microbes Infect       Date:  2018-01-10       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.